Revenue grew 22.1% year-over-year in Q1 FY2025, but operating and net income declined due to higher SG&A from recent acquisitions. Full-year guidance is unchanged, with the company positioned to benefit from ongoing digital transformation in healthcare.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.